Purpose of Activity
The activity is designed to improve the physician's knowledge about challenges in diagnosis of BKVN.
Identifi cation of Practice Gap
Many transplant providers may lack experience in diagnosing, treating and distinguishing BKVN from acute rejection. Correct diagnosis of BKVN enhances kidney allograft survival.
Learning Objectives
Upon completion of this educational activity, participants will be able to:
• Recognize pitfalls in the diagnosis of BKVN.
• Differentiate BKVN from acute rejection.
• Understand appropriate treatment strategy for BKVN.
Target Audience
This activity has been designed to meet the educational needs of physicians and surgeons in the fi eld of transplantation.
Disclosures
No commercial support has been accepted related to the development or publication of this activity. Blackwell Futura Media Services has reviewed all disclosures and resolved or managed all identifi ed confl icts of interest, as applicable.
Editor-in-Chief
Allan D. Kirk, MD, PhD, FACS, has no relevant fi nancial relationships to disclose.
Editors
Sandy Feng, MD, PhD, has no relevant fi nancial relationships to disclose. Douglas W. Hanto, MD, PhD, has no relevant fi nancial relationships to disclose.
Authors
Neeraj Singh, MD, and Millie Samaniego, MD, have no relevant fi nancial relationships to disclose.
ASTS Staff
Mina Behari, Director of Education, has no relevant fi nancial relationships to disclose. This manuscript underwent peer review in line with the standards of editorial integrity and publication ethics maintained by the American Journal of Transplantation. The peer reviewers have no relevant fi nancial relationships to disclose. The peer review process for the American Journal of Transplantation is blinded. As such, the identities of the reviewers are not disclosed in line with the standard accepted practices of medical journal peer review.
Instructions on Receiving CME Credit
This activity is designed to be completed within an hour. Physicians should claim only those credits that refl ect the time actually spent in the activity. This activity will be available for CME credit for twelve months following its publication date. At that time, it will be reviewed and potentially updated and extended for an additional twelve months.
Follow these steps to participate, answer the questions and claim your CME credit:
• Log on to https://www.wileyhealthlearning.com/ajt • Read the learning objectives, target audience, and activity disclosures.
• Read the article in print or online format.
• Refl ect on the article.
• Access the CME Exam, and choose the best answer to each question.
• Complete the required evaluation and print your CME certifi cate.
Renal Failure in a Kidney Transplant Recipient-BK Virus Nephropathy or Rejection?
A 53-year-old Hispanic female received a deceased-donor kidney transplant. Posttransplant, she achieved a baseline serum creatinine of 1.2-1.4 mg/dL. Her maintenance immunosuppression consisted of mycophenolate mofetil 720 mg twice daily, tacrolimus 6 mg twice daily and prednisone 5 mg daily. One-and-a-half years posttransplantation, patient was diagnosed with biopsy-proven BK virus nephropathy (BKVN) with a serum BK virus polymerase chain reaction (PCR) of 135,000 copies/mL. The immunosuppression was reduced (tacrolimus 3 mg twice daily and mycophenolate 360 mg twice daily). Subsequently serum creatinine improved to a baseline of 1.5-1.7 mg/dL and serum BK viremia became undetectable over the next year. She was continued on the lower immunosuppression, and 3 years posttransplantation, patient was admitted with serum creatinine of 2.5 mg/dL. Serum John Cunningham (JC) virus PCR was negative and BK virus PCR was undetectable at <5000 copies/mL. Donor-specifi c HLA antibodies were negative. The transplant kidney biopsy showed moderate interstitial fi brosis/tubular atrophy with infl ammation (Figure 1 ), focal tubulitis (star, Figure 2 ) with tubular cells showing slightly enlarged and hyperchromatic nuclei (arrow, Figure 2) . No viral cytopathic effects were identifi ed. The stain for polyomavirus showed weak (1+) nuclear staining ( Figure 3 ). The C4d stain was negative. Acute cellular rejection Banff 1B was diagnosed and patient was treated with high-dose intravenous steroids with improvement in serum creatinine to nadir of 1.8 mg/dL a week later. Subsequently, serum creatinine increased to 3.0 mg/dL a month later. A second transplant biopsy showed persistent infl ammation with stronger polyomavirus staining compared to previous biopsy. Serum BK virus PCR was now detectable at 6800 copies/mL. 
